SEARCH RESULTS FOR: "Tag: CRSP"
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2019(3)
2018(9)
CATEGORIES
Analyst Update(4)
Buzz Stocks(3)
Intraday Option Activity(2)
Midday Market Check(1)
Opening View(1)
Stock Market News(1)
Stocks On the Move(2)
Unusual Trading Activity(1)

6/7/2019 10:02 AM
The shares of CRISPR Therapeutics AG (NASDAQ:CRSP) are up 13.2% to trade at $42.18 this morning, after the drugmaker announced an expanded gene therapy collaboration with Vertex Pharmaceuticals (VRTX...
4/16/2019 10:24 AM
Two pharma names are scaling the Nasdaq this morning, thanks to favorable rulings from the Food and Drug Administration (FDA). First up is CRISPR Therapeutics AG (NASDAQ:CRSP), up 9.1% to trade at $40...
1/22/2019 12:00 PM
The shares of CRISPR Therapeutics AG (NASDAQ:CRSP) are getting hammered today, after the company entered an agreement with Germany's ProBioGen to research and develop gene-editing technology. Meanw...
12/24/2018 11:43 AM
Crispr Therapeutics AG (NASDAQ:CRSP) is trading up 9.9% at $24.98 today, after it was revealed Friday evening that cystic fibrosis specialist Vertex Pharmaceuticals (VRTX) took a 10.1% stake in the ge...
10/11/2018 9:14 AM
There's been notable movement in U.S. stock futures this morning, with a surprising consumer price index (CPI) pulling futures off their lows. The closely watched inflation gauge came in weaker th...

Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.







Partner Center